BioCentury
ARTICLE | Financial News

Syntaxin completes venture financing

November 15, 2010 8:00 AM UTC

Syntaxin Ltd., Abingdon, U.K. Business: Cancer, Endocrine, Neurology Date completed: 11/11/10 Type: Venture financing Raised: £18 million ($29 million) Investors: Lundbeckfond Ventures; Ipsen S.A.; Se...